Brought to you by

December 16, 2013 Issue:

Recent Health Care M&A Deals







Novant Health

Halifax Regional Medical Center


Medical Devices



Covidien plc

Given Imaging

$860 million




Crealta Pharmaceuticals LLC

Savient Pharmaceuticals, Inc.

$120.4 million




U.S. Physical Therapy

12-clinic physical therapy business

$1.683 million

ATI Physical Therapy Holdings, LLC

3-outpatient physical therapy businesses


Technology Deal of the Week
Last summer we highlighted Given Imaging Ltd. (NASDAQ: GIVN), a medical device company whose claim to fame is the PillCam, an innovative swallowed capsule endoscope. Last week, Covidien plc (NYSE: COV) announced it will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, or approximately $860 million, net of cash and investments acquired. Covidien gains additional scale to serve the global GI market, as Given Imaging adds a broad technology platform for visualizing, diagnosing and monitoring the digestive system……Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Charted Territory
November 2013 saw seven billion-dollar deals announced, and the combined total for the top 10 deals of the month was nearly $17 billion.  The combined deal value for the entire month was just $18.5 billion. Three of the largest deals were for Pharmaceutical targets, and two were in the Long-Term Care sector. Biotechnology, eHealth, Home Health & Hospice and Medical Devices each had one big deal.

Top 10 Health Care M&A Transactions in November 2013




Shire plc

ViroPharma Inc.

$4.2 billion

Salix Pharmaceuticals, Ltd

Santarus, Inc.

$2.6 billion

CVS Caremark

Coram LLC

$2.1 billion

Royal DSM and JLL Partners

Patheon Inc.

$1.95 bilion

Grifols S.A.

Blood transfusion diagnostics

$1.67 billion

Endo Health Solutions Inc.

Paladin Labs Inc.

$1.6 billion

Newcastle Investment Corp.

52 IL communities

$1.01 billion

Experian plc

Passport Health Communications

$850 million

CareFusion Corp.

GE’s Vital Signs division

$500 million

National Health Investors

25 IL communities

$491 million

Source: The Health Care M&A News, December 2013
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
Services Deal of the Week
Clinical research organizations (CROs) are still hot properties, especially for private equity firms that like the cash flow. Bridgeport Development Capital acquired Quotient Clinical, an early-stage drug development company, from Quotient Bioresearch Group for an undisclosed price. Last summer, Kohlberg Kravis Roberts & Co. (NYSE: KKR) purchased PRA International and later combined it with ReSearch Pharmaceutical Services. (See the October issue of Health Care M&A News for a closer look at the interest in the CRO market.)….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
In the Pipeline
VC firms are pouring their love into late-stage companies. Sutro Biopharma secured $26 million in Series D financing to fund the expansion of its proprietary immune-oncology product pipeline. Sutro is developing a new generation of protein therapeutics, including next-generation antibody drug conjugates (ADCs) and bispecific antibodies. The round was led by existing investors: Alta Partners, Amgen Ventures, Celgene Corporation, Lilly Ventures, Skyline Ventures and SV Life Sciences. Since 2003, Sutro announced it has raised $90 million….. Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Dynamic Deal Making: New Rules, New Strategies, New Opportunities
Come to the 2014 AM&AA Winter Conference, January 21-23, Scottsdale, AZ.
As the US economy finally begins to find traction in the wake of the financial crisis, the mergers and acquisitions landscape is slowly thawing as well. Sellers, buyers  and lenders – who reacted to the downturn by pulling in their oars – are starting to return to the marketplace. Smart investment bankers, private equity firms, and other deal-making professionals are finding ways to use M&A to add value for companies, investors and the economy. 
You’ll hear from a diverse roster of successful dealmakers sharing their insights about current market conditions, and how to overcome the lingering obstacles to transactions. Participate in a slate of networking opportunities, including pre-scheduled one-on-one meetings and AM&AA’s famous Deal Bash networking event: Two hours of networking tabled by screened middle market Intermediaries/Investment Bankers, all bearing deals and transaction opportunities.  

Visit this link for more information.
Free Trial to The Health Care M&A Information Source – Get instant access to the latest issue of The Health Care M&A News
Your free trial includes 2 monthly newsletter issues, weekly email alerts to the latest deals and developments in every key segment of the health care service and technology sectors, including behavioral health care, biotechnology, e-health, home health care, hospitals, laboratories, long-term care, managed care, medical devices, pharmaceuticals, physician medical groups, rehabilitation and more.Plus, you’ll receive a sample of the Health Care M&A Quartlery Report. Visit to sign up now.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Conference Partnerships… Click here to see more